合成聚合物涂层外周静脉穿刺中心静脉导管在晚期癌症患者中的有效性
Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer.
作者信息
Takezawa Yuta, Izumi Kouji, Kamijima Taiki, Machioka Kazuaki, Shima Takashi, Iwamoto Hiroaki, Nohara Takahiro, Shigehara Kazuyoshi, Kadono Yoshifumi, Seto Chikashi, Mizokami Atsushi
机构信息
Department of Urology, Toyama Prefectural Central Hospital, Toyama, Japan.
Department of Integrative Cancer Therapy and Urology, Kanazawa University, Graduate School of Medical Science, Kanazawa, Japan.
出版信息
In Vivo. 2019 May-Jun;33(3):877-880. doi: 10.21873/invivo.11553.
BACKGROUND/AIM: A peripherally inserted central catheter (PICC) is recommended for the safe administration of anticancer agents. The effectiveness of synthetic polymer-coated and non-coated PICCs was compared.
PATIENTS AND METHODS
Patients with advanced cancers who had indwelling PICCs were reviewed using their medical records. Three types of PICCs were compared in terms of complications and catheter failure.
RESULTS
A total of 90 patients were retrospectively analyzed, including 31 with Groshong PICCs, 30 with Argyle PICC kit, and 29 with Argyle PICC kit II. The incidence of catheter failure for Groshong PICC, Argyle PICC kit, and Argyle PICC kit II per 1,000 PICC days was 4.4614, 5.6617, and 0.8658, respectively. Catheter failure-free survival in the Argyle PICC kit II group was significantly better than that in the Argyle PICC kit group (p=0.0339).
CONCLUSION
Argyle PICC kit II, a synthetic polymer-coated PICC, may render longer patency and prevention of catheter failure than non-coated PICCs.
背景/目的：推荐使用外周静脉穿刺中心静脉导管（PICC）来安全地输注抗癌药物。比较了合成聚合物涂层和未涂层PICC的有效性。
患者与方法
通过病历回顾了留置PICC的晚期癌症患者。比较了三种类型PICC的并发症和导管失功率。
结果
共回顾性分析了90例患者，其中31例使用Groshong PICC，30例使用Argyle PICC套件，29例使用Argyle PICC套件II。每1000个PICC日，Groshong PICC、Argyle PICC套件和Argyle PICC套件II的导管失功率分别为4.4614、5.6617和0.8658。Argyle PICC套件II组的无导管失功生存期显著优于Argyle PICC套件组（p = 0.0339）。
结论
合成聚合物涂层的Argyle PICC套件II可能比未涂层的PICC具有更长的通畅时间并能预防导管失功。
Zotero 插件